Skip to main content

Bonstein Sara's Form 4 filing

INSMED Inc (INSM) · filed Jun 25, 2025

Accession no.
0001628280-25-033020
Filed
Jun 25, 2025
Trade date
Jun 23, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.88M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bonstein SaraCIK 0001604019Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 23, 2025Common StockMOption exerciseAcquired+35,253$18.95+$668,044.35138,665Direct
Jun 23, 2025Common StockMOption exerciseAcquired+12,636$19.74+$249,434.64151,301Direct
Jun 23, 2025Common StockSSaleDisposed−49,104$101.71F2−$4,994,367.84102,197Direct
Jun 23, 2025Common StockSSaleDisposed−8,661$102.15F3−$884,721.1593,536Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 23, 2025Common StockMOption exerciseDisposed−35,253$0.00$099,007Direct
Jun 23, 2025Common StockMOption exerciseDisposed−12,636$0.00$025,124Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This is the weighted average sales price representing 49,104 shares sold at prices ranging from $101.04 to $102.03 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F3

This is the weighted average sales price representing 8,661 shares sold at prices ranging from $102.04 to $102.61 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)